Buy SpaceX at $135 on IPO day and you’re sitting on a 37% gain. Buy it a few days later at $225 and you’re down roughly 22%. Same stock. Same company. Same Elon Musk promising Mars colonies and AI supercomputers. The only difference is timing — and timing, it turns out, is everything when a $2 trillion narrative collides with a 4% free float. If you’re wondering whether you’re paying too much, the answer often depends entirely on which day you showed up.
The Spike Was Real. So Is the Hangover.
SpaceX’s first week of trading looked like a meme stock on steroids — because structurally, it kind of was.
SpaceX listed on Nasdaq under the ticker SPCX on June 12, 2026 at $135 per share, raising roughly $75 billion — the largest U.S. IPO on record, according to Reuters. Shares opened near $150 and surged to a 52-week high of $225.64 within days, per Investing.com. One analysis found that roughly half of every tradable share changed hands in a single session. Retail traders piled in with the same feverish energy that once fueled the GameStop squeeze, except this time the target was a rocket company valued at 94 times its annual revenue.
The numbers tell a punishing story:
- IPO price: $135/share; brief peak: ~$225.64; current price: ~$185
- A buyer at $135 is up ~37%. A buyer at $225 is down ~18–22% — and closer to 25% if the stock drifts toward its recent trading floor near $172
- Morningstar pegs fair value at $63 per share, implying more than 50% downside from IPO-week prices
- CFRA initiated coverage with a “sell” rating, projecting a ~29% decline from early trading levels, citing inflated valuation expectations and significant capital requirements
- Only ~4% of shares trade freely — a tiny pool that turned early price swings into something resembling a pressure cooker
If you bought above $200, you already know what that math feels like.
The AI Merger Changed Everything — Mostly the Losses
SpaceX absorbed xAI in February 2026, effectively bolting an AI cash furnace onto an otherwise profitable rocket business.
The all-stock deal valued the combined entity at roughly $1.25 trillion, according to Sacra. The pitch was straightforward: AI supercomputers plus Starlink plus Mars equals a $2 trillion future — a scale of ambition reminiscent of the Stargate Project in its sheer capital appetite. The reality buried in the S-1 filings is rather less inspiring. SpaceX’s AI segment lost approximately $6.35 billion in 2025 and another $2.5 billion in Q1 2026 alone, per Morningstar. The legacy space and Starlink operations are profitable. xAI is what’s hemorrhaging cash — and it’s doing so at speed.
“On every measure that has ever mattered, SpaceX is expensive.” — financial commentator, via Thierry von Arvy’s Substack analysis
Debt nearly doubled in roughly 18 months, climbing from $14 billion to $29.1 billion by Q1 2026, according to the IPO filing reported by Morningstar and The Information. Capital expenditures hit $20.7 billion in 2025, per the New York Times, directed mostly at AI infrastructure. The Q1 2026 net loss came in at $4.3 billion on $4.7 billion in revenue — nearly matching the full-year 2025 loss of $4.9 billion in a single quarter.
The accumulated deficit since inception: $41.3 billion.
Your Index Fund Might Already Own This
With only 4% of shares trading freely, index inclusion could force tens of billions in passive buying — regardless of what the fundamentals say.
Nasdaq-100 and Russell benchmark inclusion could trigger an estimated $22 to $27 billion in forced buying from passive index trackers, according to analysis by Thierry von Arvy. Index funds must own the stock once it joins a benchmark, making them structural buyers that reduce available supply and amplify price dislocations. That mechanical demand helped inflate the early spike. Once momentum faded, latecomers discovered there was no fundamental floor beneath them — just narrative, leverage, and $41 billion in accumulated losses.
SpaceX may yet grow into its valuation. Starlink subscribers and launch cadence are genuine, growing assets — and bullish analysts point to positive adjusted EBITDA of roughly $6.6 billion as evidence the core business works. But buying a story at peak euphoria has always been the most expensive strategy in any speculative market, and rockets, by design, return to earth. The only question worth asking before you buy SPCX today is a simple one: which kind of investor do you want to be — the one who got in at $135, or the one still waiting to break even at $225?
